panaxydol has been researched along with Hepatocellular Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, LC; Song, L; Sun, YN; Wang, ZJ; Yin, M | 1 |
1 other study(ies) available for panaxydol and Hepatocellular Carcinoma
Article | Year |
---|---|
Induction of differentiation by panaxydol in human hepatocarcinoma SMMC-7721 cells via cAMP and MAP kinase dependent mechanism.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Differentiation; Cell Proliferation; Cell Survival; Cyclic AMP; Depression, Chemical; Diynes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Extracellular Signal-Regulated MAP Kinases; Fatty Alcohols; Humans; Liver Neoplasms; Microscopy, Electron, Transmission; Signal Transduction; Tumor Cells, Cultured | 2011 |